
Even when you don't have TB symptoms, this century-old test can still detect the disease.
Even when you don't have TB symptoms, this century-old test can still detect the disease.
Show Caption
Hide Caption
Tuberculosis history and treatment
Tuberculosis is spread through the air from one person to another, says the Center for Disease Control and Prevention.
Tuberculosis, or TB, is a disease that infects nearly 11 million people worldwide, killing some 1.25 million of them every year, per data from the World Health Organization.
A person infected with the disease may experience a range of symptoms such as a low-grade fever, coughing or fatigue on the mild end to a loss of appetite, difficulty breathing, night sweats, back and chest pain and a persistent cough (often with accompanying blood) on the more severe end.
TB is spread through airborne particles that are released when an infected person talks, sneezes or coughs and another person breathes in those particles. "It's a disease that is highly contagious," explains Amira Roess, a professor of global health and epidemiology at George Mason University in Virginia.
Detecting TB early, she adds, goes a long way toward avoiding some of the disease's worst outcomes and preventing its spread to others.
What is a TB test? What is a PPD test?
Forms of testing for TB vary depending on what stage of the disease a person is in. The three main stages of the disease are primary (exposure), latent (inactive) and active TB, each reflecting whether TB germs are still contained in the lungs or are actively wreaking havoc. Only someone with active TB has significant symptoms and can spread the disease to others, but it's still important to know if you have the less serious stages of the disease as primary and latent TB can develop into active TB at any time.
Symptoms aren't usually present in the primary or latent stage of TB, but there are still two ways to test whether TB germs are present in the body. The first of these is a blood test "which measures the body's immune response to tuberculosis proteins," explains Dr. Richard Doyle, a physician and clinical assistant professor of emergency medicine at Northwestern University.
The second diagnostic test option is known as a purified protein derivative (PPD) test, but it's commonly referred to as a TB skin test. "TB skin tests have been used in medicine for over a century," says Doyle. The skin test is administered by a healthcare professional using a small needle to inject testing materials under the skin, "typically in the forearm," says Doyle.
In case you missed: Tuberculosis is one of the deadliest infectious diseases in human history. Here's why.
How long do PPD test results take?
Results of a PPD test are not immediate because the test has to determine "if the immune system has been previously (affected) by TB exposure," says Doyle, which can take a couple of days. "If your immune system reacts to the injected protein," he explains, "it will cause a firm, raised area at the site of injection." This thickening and hardening of tissue is called an induration and the size of it is measured by your doctor in a return visit 48 to 72 hours after the initial injection took place.
If you're unable to return to the doctor within two or three days after the test is first administered, "you may be given instructions for how to read the test results yourself," says Roess.
When checked by a healthcare professional, "an induration on the skin of 15 millimeters or more is usually considered a positive TB result in healthy individuals," says Doyle. "But for people at higher risk, such as those with HIV, organ transplant recipients or people on immunosuppressive medications, an induration of just 5 millimeters may be considered positive due to their increased vulnerability to developing active TB."
Heads up: What you need to know about whooping cough
Who are PPD tests recommended for?
PPD tests are suggested for a number of reasons but "are most commonly recommended when a person has been in contact with a person infected with tuberculosis," says Dr. Cathy Hewison, a physician and tuberculosis advisor at the Paris-based humanitarian organization, Médecins Sans Frontières.
Education enrollment, new employment, traveling to or from certain countries or an immigration application can all be additional reasons a PPD test may be recommended. The U.S. Centers for Disease Control and Prevention (CDC) also suggests some groups of people be periodically tested under other circumstances. Such groups may include people who have a weakened immune system or conditions such as cancer, diabetes or HIV; if a person has been infected with TB in the past; if one is elderly; has done illegal intravenous drugs; or if one has not received proper treatment for a past TB infection.
PPD tests are also commonly recommend for people who work in homeless shelters, hospitals, prisons or nursing facilities. "Healthcare workers are routinely screened as part of occupational health protocols," says Doyle. "Patients who are about to start immunosuppressive therapies such as certain biologic agents or chemotherapy should also be screened for latent TB before treatment begins."
If exposure is detected or TB germs are found through PPD testing, Hewison says, "then preventive treatment can be offered to reduce your likelihood of developing active TB or spreading it to others."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Forbes
9 hours ago
- Forbes
Quietly Burning Out? What To Do When Your Leadership Starts Lacking
Post by Dr Katie Best, Visiting Fellow at the Department of Management at LSE, Head Tutor on MBA Essentials and Chief Examiner on Core Management Concepts. Dr Best is the author of upcoming book, The Ten Toughest Leadership Problems (and How to Solve Them) (August 2025), and Leadership Coach and Consultant at KatieBest Associates. Today's most committed leaders are often deeply helpful, hyper-responsible, and always ready to step ... More up. But that very strength can become a trap Most leaders don't realise they're burnt out—because they're still high-functioning. They're answering emails, running meetings, and hitting deadlines. But under the surface, their energy, creativity, and confidence are quietly eroding. I used to think burnout looked like someone who's at home, signed off work with stress. But I've realised more recently that burnout doesn't just live its life away from work, it lives its life at the office, sending one more email, making another tough decision, and keeping going, seemingly endlessly — surviving, but certainly not thriving. This might sound at odds with how we typically imagine burnout, but it's entirely in line with the go-to definition from the World Health Organization: a state of chronic workplace stress that hasn't been successfully managed, marked by exhaustion, cynicism, and reduced effectiveness. In my upcoming book The Ten Toughest Leadership Problems (and How to Solve Them), I talk about how overloaded leaders often try to fix burnout with better productivity tools — when the real solution lies in changing the way they lead. Whether that means delegating, narrowing focus, or letting go of unrealistic expectations, the shift has to be strategic, not reactive. Today's most committed leaders are often deeply helpful, hyper-responsible, and always ready to step up. But that very strength can become a trap—keeping them constantly on alert, always anticipating the next high-stakes decision or crisis, unable to switch off. The problem? When we're depleted, we often can't see it. We normalize the stress—tell ourselves this is just what leadership looks like. Or if we do notice we're struggling, we deny it. Surely a good night's sleep or a productivity hack will fix it? But when you're at this point, it's not just a time management issue. Rather, it's a role design issue, a personal standards issue, or others' expectations being unrealistic. And depending on which of those it is, you need a plan to help you fix it. When the workload inherent to the job is too great, it's time to look at what needs taking away. If you are doing work meant for two people, or in a job that assumes 60 hours a week from the outset, something needs to change. If the load is genuinely unmanageable, you should consider solutions such as redistributing tasks, hiring support, or renegotiating deliverables. Share the problem with others, such as HR, your seniors and peers, so that work can be started on what must be done. If you're setting your own standards too high, it's time to choose what you can afford to drop. I call this 'strategic failure'. By that, I mean that high-functioning leaders are clear on what they're willing to fail at or let slide in order to protect what matters most. Make peace with strategic failure with the unimportant things to protect success in the critical ones. Also: work isn't everything. People who reach the end of their lives and are asked their regrets don't typically (if ever) say, 'well, I just wish I'd worked harder. I didn't achieve inbox zero enough of the time.' When others expect too much, it's time to reset the narrative. That might mean clearer boundaries, more transparent capacity-setting, or simply letting others see that you're human—not a machine. The strongest leaders don't absorb every ask—they model sustainable performance for their teams. Resetting your leadership energy starts with recognising that you're not lazy, disorganised, or underperforming — you're overloaded. And the solution isn't to 'power through.' It's to make strategic choices about what gets your time, your energy, and your attention. The ultimate consequences of burnout can be serious – if a leader fails to spot a critical error, loses a key client, or makes a bad financial decision, burnout starts to have significant and far-reaching consequences. And this is without considering the serious health risks which burnout, left untreated, can bring. The strongest leaders aren't the ones who absorb it all. They're the ones who lead differently — who model focus, clarity, and enough space to think. Not just for themselves, but for the people who are watching. Follow Dr Katie Best on LinkedIn. Follow LSE's Department of Management on LinkedIn. Check out our website.
Yahoo
11 hours ago
- Yahoo
Epic charts growth in provider TEFCA adoption
This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. More than 1,000 hospitals and 22,000 clinics that use Epic are live on the federal government's health information sharing framework, the electronic health record vendor said Monday. Epic plans to transition all of its customers to the Trusted Exchange Framework and Common Agreement, or TEFCA, by the end of the year, according to Matt Doyle, Epic's Interoperability Software Development Lead. Currently 41% of Epic's customers are live with TEFCA, while 43% are working to implement the data sharing network. The remaining 16% are in planning stages, Doyle said in an emailed statement. TEFCA is a major initiative for healthcare interoperability, setting technical requirements and exchange policies for companies to pull together clinical information sharing networks across the country. The framework went live in December 2023 with five Qualified Health Information Networks, organizations that represent health systems, insurers or health IT vendors that can query and receive information from other networks. Epic's network, Epic Nexus, was one of the original QHINs designated at TEFCA's launch. The government framework lowers barriers to health data sharing, allowing more providers in rural and underserved communities to easily exchange information and improve care, Epic said Monday. The company had previously said last year it would move all of its customers onto TEFCA by the end of 2025. The number of QHINs has also expanded since TEFCA went live. This spring, e-prescribing giant Surescripts' data exchange said it had received QHIN status, bringing the number of designated information sharing networks to nine. Oracle Health, an EHR competitor with Epic, is also looking to earn QHIN designation. The technology giant submitted its application in February. Epic is a major player in healthcare technology as the nation's largest EHR vendor. The vendor controlled more than 42% of the acute care hospital market last year, according to a report published this spring by healthcare IT research firm Klas Research. Recommended Reading Surescripts receives QHIN status under TEFCA Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Axios
14 hours ago
- Axios
New COVID subvariant cases detected in Washington
More than a dozen cases of a new COVID-19 subvariant — NB.1.8.1 — have been detected in Washington, according to federal surveillance data. Why it matters: The variant has been gaining ground globally, according to the World Health Organization, and first appeared in the U.S. in March and April. Driving the news: Fourteen cases of NB.1.8.1 have been genetically sequenced in Washington based on global tracking data as of last week, according to an emailed statement from the Washington Department of Health. The earliest sample was collected on April 7, and the most recent on May 20, per DOH. One of the cases was detected in a traveler at Seattle-Tacoma International Airport after the person voluntarily provided a nasal swab on May 15 for the CDC's variant tracking program, the Washington State Standard reported. State of play: Washington's ability to spot new COVID variants early is more limited than in past years due to a steep drop in community testing and a shift toward at-home antigen tests, DOH said Monday in an emailed statement. Thirteen of the 14 detections came from Ginkgo Bioworks, which screens travelers at Sea-Tac for the CDC. One case was flagged by the U.S. Air Force School of Medicine. It's unclear in all 14 detections whether the individuals live in Washington or spent time in the state after testing, per DOH. Threat level: NB.1.8.1 has been flagged by WHO as a variant under monitoring because of its rising spread, but health officials say the public risk remains low, with no signs of increased disease severity.